Docs struggle with making MCI diagnoses, 2022 Alzheimer’s report finds
By
Alicia Lasek
Mar 23, 2022
Less than half of primary care physicians surveyed report being comfortable diagnosing mild cognitive impairment that’s due to Alzheimer’s disease. Fully 90% told researchers that it is “hard...
Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
Early Alzheimer’s diagnosis may unintentionally hamper social engagement
By
Alicia Lasek
Nov 23, 2021
Clinicians should identify strategies to alleviate the social impacts of dementia diagnoses and encourage patients to mobilize informal support networks, researchers say.
Trial begins of nasal vaccine for Alzheimer disease
Nov 18, 2021
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Having a good listener in one’s life may help slow cognitive decline: study
By
Alicia Lasek
Aug 18, 2021
Older adults who have regular interactions with active listeners are more likely to have cognitive functioning that contradicts evidence of dementia-related brain changes, a new study finds.
BREAKING: First appropriate use guidance published for Alzheimer’s drug Aduhelm
By
Alicia Lasek
Jul 27, 2021
The first set of guidelines has been published for clinicians who wish to prescribe the new drug aducanumab (Aduhelm) and to properly monitor its administration. The recommendations fill the gaps between...
CMS to weigh national Medicare coverage for Aduhelm, other Alzheimer’s drugs
By
Alicia Lasek
Jul 14, 2021
The agency is considering whether to establish a national coverage policy for monoclonal antibody drugs that treat Alzheimer’s disease, including the newly approved drug aducanumab (Aduhelm).
New behavior management guidelines support person-centered dementia care
By
Alicia Lasek
Nov 18, 2020
Properly addressing the distress that underlies dementia-related behaviors is key to improving quality of life and preventing rapid decline in these patients, according to new guidance from leading dementia...
FDA advisers to vote on first drug to treat Alzheimer’s
By
Alicia Lasek
Oct 28, 2020
Advisers will consider whether to recommend that the amyloid beta-removing drug aducanumab be approved. The FDA has not reviewed an application for a new Alzheimer’s treatment for at least 15 years.
Can grapes halve a person’s dementia risk?
By
John O'Connor
Jun 22, 2020
People who eat a handful of grapes twice a day might cut their Alzheimer’s disease risk virtually in half, a new study suggests.